BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17191351)

  • 1. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 2. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities.
    Couvreur P; Barguer D; Crommelin DJ; DuchĂȘne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E;
    Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539
    [No Abstract]   [Full Text] [Related]  

  • 3. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 4. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 5. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 6. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 8. Scripps Florida.
    Sheppard TL
    Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Alzheimer disease drug discovery and development in academia.
    Van Eldik LJ; Koppal T; Watterson DM
    Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S18-28. PubMed ID: 12070358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical drug discovery research and training at Vanderbilt.
    Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ
    ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778
    [No Abstract]   [Full Text] [Related]  

  • 12. APT drug R&D: the right active ingredient in the right presentation for the right therapeutic use.
    Cavalla D
    Nat Rev Drug Discov; 2009 Nov; 8(11):849-53. PubMed ID: 19713959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from a Recovering Academic.
    Ehlers MD
    Cell; 2016 May; 165(5):1043-1048. PubMed ID: 27203106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 15. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 19. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from 54 years of pharmaceutical research.
    Firestone RA
    Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.